跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 36,105 条关于
“urinary retention”
全部
36,105
临床试验
33,561
药物
109
机构
31
资讯
2,404
去年
FDA Approves Gemtesa (Vibegron) for Overactive Bladder in Men with BPH
8个月前
Medicus Pharma Secures Improved Teverelix License Terms and Reports Promising Phase 1 Data in Women
去年
UGN-102 Demonstrates High Complete Response Rate in Non-Muscle Invasive Bladder Cancer Trial
2年前
FDA Expands Furoscix Indication to Include NYHA Class IV Heart Failure Patients
2个月前
Rectal Spacers Show Acceptable Safety in Locally Advanced Prostate Cancer Radiotherapy
去年
UGN-102 Shows Durable Response in Low-Grade Bladder Cancer, Awaits FDA Decision
去年
Medicus Pharma to Acquire Antev for $75 Million, Gaining Novel GnRH Antagonist for Prostate Conditions
去年
Zr-89 Girentuximab PET-CT Shows Promise in Detecting Clear Cell Renal Cell Carcinoma
去年
PENG Block vs. Caudal Block for Pediatric Hip Surgery: A Comparative Study on Analgesia Efficacy
16年前
Urovant Sciences Launches GEMTESA® (vibegron) for Overactive Bladder Treatment in the U.S.
第 1 页,共 241 页
上一页
下一页